BALDWIN WEALTH PARTNERS LLC/MA

Position in LGND — Ligand Pharmaceuticals Inc

CIK 1021258 Marion, MA

Position in LGND

as of Jun 30, 2026 · filed Jul 14, 2026 Compact

Position Value

$287,957

-$71,866 QoQ

Shares Held

911

-74.7% QoQ

Ownership

0.005%

of shares outstanding

% of Portfolio

0.02%

of 13F equity value

Holder Rank

#29

of 52 holders

Holding Since

Sep 2024

2 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

BALDWIN WEALTH PARTNERS LLC/MA holds $21,986,639 across 4 Biotechnology names. LGND ranks #4 (1.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	AXSM	Axsome Therapeutics, Inc.	44,070	$10,787,013
2	NVCT	Nuvectis Pharma, Inc.	382,015	$7,025,255
3	VRTX	Vertex Pharmaceuticals Inc / Ma	7,824	$3,886,414
4	LGND	Ligand Pharmaceuticals Inc This page	911	$287,957

2 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$287,957	911	-74.7%	Shares	Sole	2026-07-14
2024-09-30	$359,823	3,595	—	Shares	Sole	2024-10-16
No filing history on record for this holder in this stock.